Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03385707 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypoglycemia and the Gut Microbiome

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Sep 2024 to Nov 1, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  2. Primary completion date: Sep 2023 to Sep 2024v9
  3. Phase: Not applicable to Not specified
    • Study completion date: Sep 2023 to Sep 2024
    • Interventions: Dexcom continuous glucose monitor and activity monitor (Device) to not stated
    v8
  4. Primary and study completion dates: May 2023 to Sep 2023v7
  5. Primary and study completion dates: Nov 2022 to May 2023v6
Show 4 earlier versionsHide 4 earlier versions
  1. Re-verified, no change to tracked fieldsv5
  2. Primary and study completion dates: Nov 2019 to Nov 2022v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Nov 2018 to Nov 2019
    • Start date changed from estimate of Apr 2018 to Feb 7, 2019
    • Study sites: 0 to 1
    v3
  4. Start date: Dec 2017 to Apr 2018v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is designed to evaluate individuals who are currently experiencing symptoms of hypoglycemia, in order to discern correlations between microbiome composition and patterns of postprandial glycemia.
Trial Details
NCT Number NCT03385707
Lead Sponsor Joslin Diabetes Center
Conditions
(from sponsor)		 Hypoglycemia
Related terms Hypoglycemia
Enrollment 28 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov